The deal is the first of potentially ‘multiple’ such agreements to support manufacture of COVID-19 vaccines. The agreement sees Novartis provide aseptic manufacturing services from its Stein, Switzerland, facility for the production of Pfizer and BioNTech’s COVID-19 vaccine. Novartis will provide the services under a contract manufacturing agreement that sees the company take bulk mRNA active ingredient from BioNTech and fill this into vials, before shipping the vials back to BioNTech for distribution. The Swiss company announced that it would…